Crinetics (CRNX) grants RSUs and stock options to board director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Crinetics Pharmaceuticals director Caren Deardorf received new equity awards in the form of restricted stock units and stock options. She was granted 5,925 restricted stock units, representing the right to receive the same number of common shares, which vest 100% on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to her continued board service.
She was also granted stock options covering 9,730 shares of common stock at an exercise price of $35.87 per share, expiring on June 18, 2036, with the same vesting schedule. Following these awards, she directly holds 22,225 shares of common stock, in addition to the new option position.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Deardorf Caren
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,730 | $0.00 | -- |
| Grant/Award | Common Stock | 5,925 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,730 shares (Direct, null);
Common Stock — 22,225 shares (Direct, null)
Footnotes (1)
- The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Restricted stock units granted: 5,925 shares
Stock options granted: 9,730 options
Option exercise price: $35.87 per share
+2 more
5 metrics
Restricted stock units granted
5,925 shares
Equity award granted June 18, 2026
Stock options granted
9,730 options
Right to buy common stock
Option exercise price
$35.87 per share
Stock option strike price
Option expiration date
June 18, 2036
Option term end date
Shares held after RSU grant
22,225 shares
Direct common stock holdings following transaction
Key Terms
restricted stock units, stock option, vest, exercise price
4 terms
restricted stock units financial
"involves the receipt of restricted stock units, which represent the right to receive shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"The stock option shall vest and become exercisable on the earlier of (a) the first anniversary"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"100% vesting on the earlier of (a) the first anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"Stock Option (Right to Buy) ... conversion_or_exercise_price: "35.8700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What equity awards did Caren Deardorf receive from Crinetics (CRNX)?
Caren Deardorf received 5,925 restricted stock units and stock options for 9,730 shares of Crinetics common stock. The options carry a $35.87 exercise price and expire June 18, 2036, providing equity compensation tied to her service as a director.
When do Caren Deardorf’s new Crinetics (CRNX) awards vest?
Both the restricted stock units and stock options vest 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual stockholder meeting. Vesting requires her continued service on Crinetics’ board through that vesting date.
What is the exercise price and term of Caren Deardorf’s Crinetics stock options?
The stock options cover 9,730 shares of Crinetics common stock at an exercise price of $35.87 per share. They expire on June 18, 2036 and follow the stated vesting schedule before becoming exercisable by the director.
Are Caren Deardorf’s new Crinetics awards open-market purchases or compensation grants?
These transactions are compensation-related grants, not open-market purchases or sales. The Form 4 shows them with code “A” for grant, award, or other acquisition, reflecting restricted stock units and stock options tied to her board service and vesting conditions.